Retina Consultants of Southern Colorado

What Retina Consultants of Southern Colorado does

Retina Consultants of Southern Colorado is a physician-owned, board-certified ophthalmology sub-specialty practice founded in 1987, dedicated exclusively to the diagnosis, medical treatment, and surgical management of retinal, macular, and vitreous diseases. The practice operates three physical clinic locations across Southern Colorado — Colorado Springs North, Colorado Springs Central, and Pueblo — staffed by eight fellowship-trained retina specialists and vitreoretinal surgeons who collectively treat conditions including age-related macular degeneration (wet, dry, and geographic atrophy), diabetic retinopathy, retinal tears and detachments, macular holes, epiretinal membranes, retinal vein occlusions (BRVO and CRVO), uveitis, and flashes/floaters.

The practice's clinical capability rests on specialized ophthalmic technology: high-resolution optical coherence tomography (OCT), fluorescein angiography (FA), OCT angiography (OCTA), fundus photography, ocular ultrasound (B-scan), and surgical platforms supporting small-gauge vitrectomy, scleral buckle, laser photocoagulation, and intravitreal injection administration (anti-VEGF agents such as Eylea, Vabysmo, Lucentis; complement inhibitors such as Syfovre and Izervay; corticosteroids such as Ozurdex, Yutiq, and Retisert). In December 2025, the practice launched a Patient WebApp powered by Promptly to digitize intake and billing workflows.

The business model is fee-for-service professional services billed to insurance for office consultations, diagnostic imaging, in-office injection treatments, and surgical procedures performed at affiliated surgical facilities. The practice generates a secondary revenue stream through participation in 10 active clinical trials across 8 retinal conditions in partnership with major pharmaceutical sponsors (Roche, REGENXBIO, Iveric Bio, Alexion, Opthea, Alimera, Oxurion, EyePoint, Clover Therapeutics, and Lowy Medical Research Institute). Patient acquisition runs primarily through referral relationships with primary care physicians, optometrists, and ophthalmologists, supplemented by self-referrals and a content-marketing presence. The practice is a member of the Retina Consultants of America network and serves a regional, multilingual patient base across the Front Range region.

Name

Retina Consultants of Southern Colorado

Legal name

Retina Consultants of Southern Colorado

Website

https://coloradoretina.com

Company type

Private

Founded year

1987

Operating status

Operating

Headcount range

51–100 employees

Short description

Retina Consultants of Southern Colorado is a physician-owned retinal care practice founded in 1987, operating three clinics across Southern Colorado with eight board-certified retina specialists providing diagnostic, medical, and surgical treatment for retinal diseases and an active clinical trials program.

Ownership category

akta.pro rank

Product category

Retinal Care Services (Specialty Ophthalmology)

NAICS

Offices of Physicians (62111)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro industry

PRIMARYHLAKAKAE

Retina & Vitreous Specialists

Healthcare & Life Sciences/Specialist Medical Practice/Ophthalmology & Optometry

SECONDARYHLAKAKAO

Ambulatory Surgery Centers (Ophthalmic/Outpatient Eye Surgery)

Healthcare & Life Sciences/Specialist Medical Practice/Ophthalmology & Optometry

SECONDARYHLAKAKAN

Ocular Imaging & Diagnostic Testing Centers

Healthcare & Life Sciences/Specialist Medical Practice/Ophthalmology & Optometry

Keywords

• Retinal care services
• Vitreoretinal surgery
• Intravitreal injections
• Retinal diagnostics
• Ophthalmology practice

Headquarters

HQ city

Colorado Springs

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Medical and Surgical Retina Care Services: Fee-for-service medical practice providing diagnostic, treatment, and surgical services for retinal diseases. Services include office consultations, diagnostic testing, intravitreal injections, laser treatments, vitrectomy, and scleral buckle surgeries. Revenue is generated through patient visits, procedures, and surgeries billed to insurance.
2. Clinical Trial Research Services: Participation in clinical trials provides access to cutting-edge treatments while contributing to medical research. Patients may receive investigational treatments through trial participation.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels5 records

Core offering

Retina Consultants of Southern Colorado is a retinal care medical practice that diagnoses and treats medical and surgical diseases of the retina, macula, and vitreous body. Services encompass in-office diagnostic testing (OCT, fluorescein angiography, OCT angiography, fundus photography, ocular ultrasound), intravitreal injection treatments (anti-VEGF, complement inhibitors, corticosteroids), and vitreoretinal surgeries (vitrectomy, scleral buckle). The practice also operates an award-winning clinical research program offering patients access to investigational therapies through approximately 10 active clinical trials across multiple retinal conditions.

Product overview

Retina Consultants of Southern Colorado is a specialized retina care medical practice offering a comprehensive range of diagnostic and treatment services for retinal, macular, and vitreous diseases. The practice operates three convenient locations in Colorado Springs and Pueblo. Core clinical services include advanced diagnostic testing (OCT, fluorescein angiography, OCT angiography, fundus photography, ocular ultrasound), in-office intravitreal injection treatments (anti-VEGF medications, complement inhibitors, corticosteroids), and surgical interventions (vitrectomy, scleral buckle). The practice also runs an award-winning clinical research program (13 industry awards) offering trials across eight condition categories. Patient-facing digital services include a Patient WebApp for online check-in and payments. The practice treats conditions including age-related macular degeneration (dry and wet), geographic atrophy, diabetic retinopathy, retinal tears and detachments, macular holes, epiretinal membranes, retinal vein occlusions (BRVO and CRVO), uveitis, and more.

Differentiator

Problem solved

Functional benefit

Products and services

• Patient WebApp A secure, digital patient portal powered by Promptly that enables patients to accelerate check-in by updating demographics and signing consent forms ahead of time, track tasks via a dashboard, and make online payments.
• Intravitreal Injections In-office sight-saving treatment delivering medication directly into the eye for conditions including age-related macular degeneration (AMD), geographic atrophy, diabetic macular edema, diabetic retinopathy, and retinal vein occlusion. Includes anti-VEGF medications (Eylea, Vabysmo, Lucentis, Cimerli, Avastin), complement inhibitors (Syfovre, Izervay), and corticosteroids (Ozurdex, Yutiq, Retisert).
• Vitrectomy Microsurgical procedure removing the vitreous gel from inside the eye to repair retinal detachment, close macular holes, remove epiretinal membranes, clear vitreous hemorrhage, treat diabetic retinopathy complications, and address other sight-threatening conditions.
• Scleral Buckle Surgical procedure placing a silicone buckle element around the outside of the eye to support and repair the retina from outside, primarily used for retinal detachment and certain retinal tears.
• Diagnostic Testing Comprehensive retinal diagnostic services including dilated eye examination, optical coherence tomography (OCT), fluorescein angiography (FA), fundus photography, ocular ultrasound (B-Scan), and OCT angiography (OCTA) for comprehensive retinal evaluation.
• Clinical Trials Program Active clinical trial program offering patients access to experimental treatments across multiple conditions including diabetic macular edema, dry AMD, wet AMD, uveitis, macular telangiectasia, nonproliferative diabetic retinopathy, branch retinal vein occlusion, and central retinal vein occlusion. Currently enrolling and partnering with sponsors including Alimera, Iveric Bio, REGENXBIO, Roche, Opthea, Alexion, Oxurion, EyePoint Pharmaceuticals, Lowy Medical Research Institute, and Clover Therapeutics.

Quantifiable outcome

• 30+ years of excellence serving Southern Colorado with established reputation for innovation
• +2 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Eleven partnerships are on record, tiered core and minor.

• Retina Consultants of AmericacoreStrategic or Co-development PartnerThe practice is part of Retina Consultants of America, a network of leading retinal care and research practices in the United States. This affiliation enables referral of traveling patients to specialists across the country, ensuring continuity of care for patients who travel out of town.
• Alimera SciencesminorStrategic or Co-development PartnerClinical trial partnership for Alimera 01-20-005 study evaluating ILUVIEN for diabetic macular edema (CI-DME).
• OxurionminorStrategic or Co-development PartnerClinical trial partnership for Oxurion THR-687-002 study assessing THR-687 for diabetic macular edema treatment.
• Iveric BiominorStrategic or Co-development PartnerClinical trial partnership for Iveric ISEE2008 Phase 3 study of Zimura (complement C5 inhibitor) for geographic atrophy secondary to AMD.
• Clover TherapeuticsminorStrategic or Co-development PartnerResearch partnership focused on understanding how genetics and lifestyle affect Age-related Macular Degeneration through observation study.
• AlexionminorStrategic or Co-development PartnerClinical trial partnership for Alexion ALXN2040-GA-201 study of Danicopan for geographic atrophy secondary to AMD.
• OptheaminorStrategic or Co-development PartnerClinical trial partnership for Opthea OPT-302-1004 Phase 3 study of OPT-302 for neovascular age-related macular degeneration.
• REGENXBIOminorStrategic or Co-development PartnerClinical trial partnership for REGENXBIO RGX-314-2104 study evaluating RGX-314 gene therapy for neovascular wet AMD.
• EyePoint PharmaceuticalsminorStrategic or Co-development PartnerRegistry study partnership for EyePoint Yutiq EYP-YUT-0001 collecting real-world data on Yutiq fluocinolone acetonide intravitreal implant for chronic non-infectious uveitis.
• Lowy Medical Research InstituteminorStrategic or Co-development PartnerNatural history observation and registry study partnership for macular telangiectasia type 2 (MacTel).
• RocheminorStrategic or Co-development PartnerMultiple clinical trial partnerships with Roche including BP41321 (diabetic retinopathy), GR41984 BRVO, and GR41986 CRVO studies.

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• Retina Consultants of America: Parent network of leading retinal care and research practices across the U.S., of which Retina Consultants of Southern Colorado is an affiliate. Operates as the umbrella organization for the most relevant comparable peer set of independent retina specialty practices sharing referral, clinical trial, and back-office infrastructure.
• Wills Eye Hospital: Philadelphia-based academic eye hospital and one of the oldest and largest U.S. eye care institutions, offering subspecialty retina services including vitreoretinal surgery and clinical research. Comparable as a competing specialty referral destination for complex retinal cases in its region, though broader in scope.
• Bascom Palmer Eye Institute: University of Miami-based academic ophthalmology department consistently ranked among the top eye hospitals in the U.S. Comparable as a destination provider for complex retinal disease (including surgery and clinical trials) and a competing source of tertiary referrals, though operating under an academic rather than private-practice model.
• Cincinnati Eye Institute: A large multi-specialty ophthalmology and retina practice in the Midwest offering a broader service portfolio (cataract, glaucoma, oculoplastics in addition to retina). Comparable as a regionally dominant physician-led eye care group with retinal specialists and clinical research, though broader in scope than a pure retina practice.

Direct peers

• Mid Atlantic Retina: A multi-location retinal specialty practice in the Mid-Atlantic region providing medical, surgical, and clinical trial services for retinal diseases. Directly comparable as a multi-physician retina-only specialty group with similar service mix (vitrectomy, anti-VEGF injections, OCT diagnostics) and referral-driven GTM.
• California Retina Consultants: Multi-office retinal specialty practice serving California with a strong clinical research program. Comparable across dimensions of scale (multi-physician specialist group), service mix (vitreoretinal surgery plus intravitreal injections plus OCT diagnostics), and clinical trial participation strategy.
• Associated Retina Consultants: Multi-physician retina-only specialty practice in the Midwest serving Michigan and surrounding states. Highly comparable as a private-practice retinal group with similar clinical capabilities (intravitreal injections, vitrectomy, retinal imaging) and patient population.
• New England Retina Associates: Multi-physician retinal specialty practice serving the New England region with medical, surgical, and clinical research services for retinal diseases. Comparable in scale, specialty focus, and referral-driven business model to a similar multi-location retina specialty group.
• Retina Consultants of Texas: Another leading retina specialty practice operating under the Retina Consultants of America umbrella with a large physician base and active clinical trials program. Highly comparable in clinical focus (medical and surgical retinal care, vitreoretinal surgery, intravitreal injections) and business model (private specialty practice, referral-driven, trial participation).

Regional players

• Colorado Springs Eye Consultants: Multi-physician ophthalmology practice serving the Colorado Springs market offering general ophthalmology and cataract services. Comparable as a competing eye care provider in the same local geography, though broader in service mix and not retina-specialized.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/RetinaConsultantsSouthernColorado
• LinkedInlinkedin.com/company/retina-consultants-of-southern-colorado

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Retina Consultants of Southern Colorado